Safety of the Herpes Zoster Subunit Vaccine in Lupus

Abroad (travel likely)RecruitingPHASE4

Conditions

Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • NYU Langone Health, New York, New York, United States

    Contact: Principal Investigator (Amit Saxena, MD)
  • Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Cristina Arriens) · cristina-arriens@omrf.org · 405-271-7303
Study leads
  • Amit Saxena, MD

    Principal Investigator

    NYU Langone Health